Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-07-23 Sale |
2024-07-25 4:05 pm |
Sagimet Biosciences Inc. | SGMT | Kemble George Executive Chairman |
23,625 | $3.1674 | $74,830 | 118,693 (Direct) |
View |
| 2024-07-19 Sale |
2024-07-23 4:06 pm |
Sagimet Biosciences Inc. | SGMT | Martins Eduardo Bruno Chief Medical Officer |
8,357 | $3.1004 | $25,910 | 81,213 (Direct) |
View |
| 2024-07-19 Sale |
2024-07-23 4:05 pm |
Sagimet Biosciences Inc. | SGMT | Rozek Elizabeth General Counsel and CCO |
10,914 | $3.0997 | $33,830 | 160,506 (Direct) |
View |
| 2024-07-19 Sale |
2024-07-23 4:05 pm |
Sagimet Biosciences Inc. | SGMT | Kemble George Executive Chairman |
14,062 | $3.1009 | $43,605 | 142,318 (Direct) |
View |
| 2024-03-26 Purchase |
2024-03-28 4:08 pm |
Sagimet Biosciences Inc. | SGMT | Happel David President & CEO |
12,100 | $5.267 | $63,731 | 639,200 (Direct) |
View |
| 2023-12-07 Purchase |
2023-12-08 4:05 pm |
Sagimet Biosciences Inc. | SGMT | Happel David President & CEO |
1,600 | $4.1 | $6,560 | 627,100 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-06-09 Option Award |
2025-06-10 5:43 pm |
N/A 2035-06-08 |
Sagimet Biosciences Inc. | SGMT | Walbert Timothy P Director |
32,250 | $0 | 32,250 (Direct) |
View |
| 2025-06-06 Option Award |
2025-06-10 5:42 pm |
N/A 2035-06-05 |
Sagimet Biosciences Inc. | SGMT | SEIDENBERG BETH C Director |
60,772 | $0 | 60,772 (Direct) |
View |
| 2025-06-09 Option Award |
2025-06-10 5:41 pm |
N/A 2035-06-08 |
Sagimet Biosciences Inc. | SGMT | Phillips Anne M. Director |
27,268 | $0 | 27,268 (Direct) |
View |
| 2025-06-09 Option Award |
2025-06-10 5:40 pm |
N/A 2035-06-08 |
Sagimet Biosciences Inc. | SGMT | Kemble George Director |
32,250 | $0 | 32,250 (Direct) |
View |
| 2025-06-09 Option Award |
2025-06-10 5:38 pm |
N/A 2035-06-08 |
Sagimet Biosciences Inc. | SGMT | Jarrett Jennifer Director |
27,268 | $0 | 27,268 (Direct) |
View |
| 2025-06-09 Option Award |
2025-06-10 5:37 pm |
N/A 2035-06-08 |
Sagimet Biosciences Inc. | SGMT | Hoelscher Paul W. Director |
32,250 | $0 | 32,250 (Direct) |
View |
| 2025-06-09 Option Award |
2025-06-10 5:36 pm |
N/A 2035-06-08 |
Sagimet Biosciences Inc. | SGMT | GRAMMER ELIZABETH A Director |
32,250 | $0 | 32,250 (Direct) |
View |
| 2025-02-06 Option Award |
2025-02-07 4:44 pm |
N/A 2035-02-05 |
Sagimet Biosciences Inc. | SGMT | Martins Eduardo Bruno Chief Medical Officer |
172,000 | $0 | 253,213 (Direct) |
View |
| 2025-02-06 Option Award |
2025-02-07 4:43 pm |
N/A 2035-02-05 |
Sagimet Biosciences Inc. | SGMT | Happel David President & CEO |
588,000 | $0 | 1,227,200 (Direct) |
View |
| 2025-02-06 Option Award |
2025-02-07 4:42 pm |
N/A 2035-02-05 |
Sagimet Biosciences Inc. | SGMT | Rozek Elizabeth General Counsel and CCO |
172,000 | $0 | 332,506 (Direct) |
View |
| 2025-02-06 Option Award |
2025-02-07 4:41 pm |
N/A 2035-02-05 |
Sagimet Biosciences Inc. | SGMT | Chauche Thierry Chief Financial Officer |
86,000 | $0 | 86,000 (Direct) |
View |
| 2024-08-01 Option Award |
2024-08-05 4:09 pm |
N/A 2034-07-31 |
Sagimet Biosciences Inc. | SGMT | Jarrett Jennifer Director |
113,895 | $0 | 113,895 (Direct) |
View |
| 2024-08-01 Option Award |
2024-08-05 4:08 pm |
N/A 2034-07-31 |
Sagimet Biosciences Inc. | SGMT | Phillips Anne M. Director |
113,895 | $0 | 113,895 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:08 pm |
N/A 2034-06-04 |
Sagimet Biosciences Inc. | SGMT | Walbert Timothy P Director |
9,279 | $0 | 9,279 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:07 pm |
N/A 2034-06-04 |
Sagimet Biosciences Inc. | SGMT | SEIDENBERG BETH C Director |
51,459 | $0 | 51,459 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:07 pm |
N/A 2034-06-04 |
Sagimet Biosciences Inc. | SGMT | Parsey Merdad Director |
51,459 | $0 | 51,459 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:05 pm |
N/A 2034-06-04 |
Sagimet Biosciences Inc. | SGMT | Hoelscher Paul W. Director |
9,279 | $0 | 9,279 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:05 pm |
N/A 2034-06-04 |
Sagimet Biosciences Inc. | SGMT | GRAMMER ELIZABETH A Director |
51,459 | $0 | 51,459 (Direct) |
View |
| 2024-05-06 Option Award |
2024-05-08 4:06 pm |
N/A 2034-05-05 |
Sagimet Biosciences Inc. | SGMT | Chauche Thierry Chief Financial Officer |
587,181 | $0 | 587,181 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 8:19 pm |
N/A 2034-03-31 |
Sagimet Biosciences Inc. | SGMT | Walbert Timothy P Director |
73,014 | $0 | 73,014 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 8:17 pm |
N/A 2034-03-31 |
Sagimet Biosciences Inc. | SGMT | Hoelscher Paul W. Director |
73,014 | $0 | 73,014 (Direct) |
View |
Ownership |
2024-04-03 8:15 pm |
N/A N/A |
Sagimet Biosciences Inc. | SGMT | Walbert Timothy P Director |
0 | $0 | 2,200 (Direct) |
View |
| 2024-01-29 Other |
2024-01-31 5:00 pm |
N/A N/A |
Sagimet Biosciences Inc. | SGMT | SANDELL SCOTT D 10% Owner |
1,117,947 | $0 | 1,385,894 (Indirect) |
View |
| 2024-01-29 Other |
2024-01-31 4:59 pm |
N/A N/A |
Sagimet Biosciences Inc. | SGMT | KERINS PATRICK J 10% Owner |
1,124,089 | $0 | 1,398,178 (Indirect) |
View |
| 2024-01-29 Other |
2024-01-31 4:57 pm |
N/A N/A |
Sagimet Biosciences Inc. | SGMT | BASKETT FOREST 10% Owner |
1,122,250 | $0 | 1,394,500 (Indirect) |
View |
| 2024-01-29 Other |
2024-01-31 4:56 pm |
N/A N/A |
Sagimet Biosciences Inc. | SGMT | NEA Partners 13 Limited Partnership NEA 13 GP Ltd 10% Owner |
1,110,950 | $0 | 4,372,175 (Indirect) |
View |
| 2024-01-29 Other |
2024-01-31 4:55 pm |
N/A N/A |
Sagimet Biosciences Inc. | SGMT | NEW ENTERPRISE ASSOCIATES 13 LP 10% Owner |
850,000 | $0 | 3,850,275 (Direct) |
View |
| 2023-11-17 Option Award |
2023-11-21 4:25 pm |
N/A N/A |
Sagimet Biosciences Inc. | SGMT | Rozek Elizabeth General Counsel and CCO |
171,420 | $0 | 171,420 (Direct) |
View |
| 2023-11-17 Option Award |
2023-11-21 4:23 pm |
N/A N/A |
Sagimet Biosciences Inc. | SGMT | Martins Eduardo Bruno Chief Medical Officer |
89,570 | $0 | 89,570 (Direct) |
View |